Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tocagen Inc (TOCA)

Tocagen Inc (TOCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tocagen Inc 4242 CAMPUS POINT COURT SUITE 500 SAN DIEGO CA 92121 USA

www.tocagen.com P: 858-412-8400

Description:

Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company which focuses on retroviral gene therapy platforms. The company's lead product candidate consists of Toca 511 & Toca FC, initially for the treatment of recurrent high grade glioma, a disease with a significant unmet medical need. Tocagen, Inc. is based in San Diego, United States.

Key Statistics

Overview:

Market Capitalization, $K 30,138
Shares Outstanding, K 23,919
Annual Sales, $ 40 K
Annual Net Income, $ -63,520 K
Last Quarter Sales, $ 10 K
Last Quarter Net Income, $ -10,580 K
60-Month Beta 0.01
% of Insider Shareholders 10.90%
% of Institutional Shareholders 21.42%
Float, K 21,312
% Float 89.10%

Growth:

1-Year Return -78.24%
3-Year Return -90.97%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/05/20
Earnings Per Share ttm -2.68
EPS Growth vs. Prev Qtr 2.27%
EPS Growth vs. Prev Year 41.89%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TOCA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -327.74%
Return-on-Assets % -111.87%
Profit Margin % -158,800.00%
Debt/Equity 1.88
Price/Sales 870.39
Price/Cash Flow N/A
Price/Book 14.48
Book Value/Share 0.45
Interest Coverage -15.63
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar